Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-065900

Options or other derivatives

  • Chief Commercial Officer acquired 525,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Pinnow Cole Chief Commercial Officer 2024-05-25 Grant or award · Stock Option (Right to Buy) +525,000 525,000 D
Loading xslF345X05/ownership.xml…